MaxCyte, Inc. (NASDAQ:MXCT – Get Rating) Director Richard Douglas acquired 80,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 29th. The stock was bought at an average price of $4.32 per share, with a total value of $345,600.00. Following the transaction, the director now directly owns 100,000 shares in the […]
Related Keywords
Blackrock , Massachusetts , United States , Richard Douglas , Massachusetts Financial Services Co , Vanguard Group Inc , Nasdaq , Millennium Management , Maxcyte Inc , Blackrock Inc , Get Rating , Director Richard Douglas , Water Life Science Advisors , Financial Services , Maxcyte Daily , Maxcyte , Nasdaq Mxct , Mxct , Medical , Insider Trading , Nsider Trades , Stocks ,
comparemela.com © 2020. All Rights Reserved.